Is Vertex Pharmaceuticals Incorporated (VRTX) a Buy, Sell, or Hold?
Vertex Pharmaceuticals Incorporated
NASDAQ:VRTX
$474.52 USD
-$1.79 (-0.38%)
- Volume
- 10.9K
- Average Volume
- 1.49M
- Market Capitalization
- $120.44B
- P/E Ratio
- 27.90
- Dividend Yield
- 0.00%
- Price Target
- $572.00
- Year High
- $533.67
- Year Low
- $362.50
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.02
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
69
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
146
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 680.55K
VRTX Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
VRTX Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Tatsis Ourania | officer: EVP, Chief Reg. & Quality Off. | 2026-07-02 | S-Sale | 524.99 | 2026-07-07 |
| McKechnie Duncan | officer: EVP, Chief Commercial Officer | 2026-07-02 | S-Sale | 519 | 2026-07-07 |
| Liu Joy | officer: EVP and Chief Legal Officer | 2026-07-01 | S-Sale | 502.71 | 2026-07-06 |
| Bozic Carmen | officer: EVP and CMO | 2026-06-26 | S-Sale | 482.5 | 2026-06-30 |
| Bozic Carmen | officer: EVP and CMO | 2026-06-18 | S-Sale | 462.17 | 2026-06-23 |
| Bozic Carmen | officer: EVP and CMO | 2026-06-15 | S-Sale | 450 | 2026-06-17 |
| Bozic Carmen | officer: EVP and CMO | 2026-06-05 | S-Sale | 450 | 2026-06-09 |
| Bozic Carmen | officer: EVP and CMO | 2026-05-29 | S-Sale | 450 | 2026-06-02 |
| Bunnage Mark E. | officer: EVP, Chief Scientific Officer | 2026-05-15 | S-Sale | 453.45 | 2026-05-19 |
| Bozic Carmen | officer: EVP and CMO | 2026-05-15 | S-Sale | 453.45 | 2026-05-19 |
| Bozic Carmen | officer: EVP and CMO | 2026-05-12 | S-Sale | 450 | 2026-05-14 |
| Upadhyay Suketu | director | 2026-05-01 | A-Award | 0 | 2026-05-05 |
| Upadhyay Suketu | director | 2026-05-01 | A-Award | 424.45 | 2026-05-05 |
| Upadhyay Suketu | director | 2026-05-01 | D-Return | 0 | 2026-05-05 |
| Thornberry Nancy | director | 2026-05-01 | A-Award | 0 | 2026-05-05 |
| Thornberry Nancy | director | 2026-05-01 | D-Return | 0 | 2026-05-05 |
| Thornberry Nancy | director | 2026-05-01 | A-Award | 424.45 | 2026-05-05 |
| Thornberry Nancy | director | 2026-05-01 | A-Award | 0 | 2026-05-05 |
| Schneider Jennifer | director | 2026-05-01 | A-Award | 0 | 2026-05-05 |
| Schneider Jennifer | director | 2026-05-01 | A-Award | 424.45 | 2026-05-05 |
| Schneider Jennifer | director | 2026-05-01 | D-Return | 0 | 2026-05-05 |
| Schneider Jennifer | director | 2026-05-01 | A-Award | 0 | 2026-05-05 |
| SACHS BRUCE I | director | 2026-05-01 | A-Award | 424.45 | 2026-05-05 |
| MCKENZIE DIANA | director | 2026-05-01 | A-Award | 0 | 2026-05-05 |
| MCKENZIE DIANA | director | 2026-05-01 | A-Award | 0 | 2026-05-05 |
| MCKENZIE DIANA | director | 2026-05-01 | D-Return | 0 | 2026-05-05 |
| Liu Joy | officer: EVP and Chief Legal Officer | 2026-05-01 | S-Sale | 425.02 | 2026-05-05 |
| Lagarde Michel | director | 2026-05-01 | A-Award | 424.45 | 2026-05-05 |
| Garber Alan M | director | 2026-05-01 | A-Award | 0 | 2026-05-05 |
| Garber Alan M | director | 2026-05-01 | A-Award | 424.45 | 2026-05-05 |
| CARNEY LLOYD | director | 2026-05-01 | A-Award | 424.45 | 2026-05-05 |
| Bhatia Sangeeta N. | director | 2026-05-01 | A-Award | 0 | 2026-05-05 |
| Bhatia Sangeeta N. | director | 2026-05-04 | S-Sale | 423.73 | 2026-05-05 |
| Upadhyay Suketu | director | 2026-04-15 | A-Award | 0 | 2026-04-17 |
| SACHS BRUCE I | director | 2026-04-15 | A-Award | 0 | 2026-04-17 |
| Garber Alan M | director | 2026-04-15 | A-Award | 0 | 2026-04-17 |
| Liu Joy | officer: EVP and Chief Legal Officer | 2026-04-01 | S-Sale | 449.17 | 2026-04-03 |
| Bozic Carmen | officer: EVP and CMO | 2026-03-27 | S-Sale | 450.95 | 2026-03-31 |
| Bozic Carmen | officer: EVP and CMO | 2026-03-13 | S-Sale | 481.79 | 2026-03-17 |
| McKechnie Duncan | officer: EVP, Chief Commercial Officer | 2026-03-11 | S-Sale | 498.42 | 2026-03-13 |
| McKechnie Duncan | officer: EVP, Chief Commercial Officer | 2026-03-04 | S-Sale | 475.3 | 2026-03-06 |
| Liu Joy | officer: EVP and Chief Legal Officer | 2026-03-02 | S-Sale | 495.96 | 2026-03-04 |
| Liu Joy | officer: EVP and Chief Legal Officer | 2026-03-01 | 0 | 2026-03-03 | |
| Liu Joy | officer: EVP and Chief Legal Officer | 2026-03-01 | 187.53 | 2026-03-03 | |
| Liu Joy | officer: EVP and Chief Legal Officer | 2026-03-01 | 155.57 | 2026-03-03 | |
| Kewalramani Reshma | director, officer: CEO & President | 2026-02-27 | S-Sale | 479.75 | 2026-03-03 |
| Kewalramani Reshma | director, officer: CEO & President | 2026-02-27 | S-Sale | 481.5 | 2026-03-03 |
| Kewalramani Reshma | director, officer: CEO & President | 2026-02-27 | S-Sale | 482.84 | 2026-03-03 |
| Kewalramani Reshma | director, officer: CEO & President | 2026-02-27 | S-Sale | 487.13 | 2026-03-03 |
| Kewalramani Reshma | director, officer: CEO & President | 2026-02-27 | S-Sale | 488.27 | 2026-03-03 |
| Kewalramani Reshma | director, officer: CEO & President | 2026-02-27 | S-Sale | 489.32 | 2026-03-03 |
| Kewalramani Reshma | director, officer: CEO & President | 2026-02-27 | S-Sale | 490.54 | 2026-03-03 |
| Kewalramani Reshma | director, officer: CEO & President | 2026-02-27 | S-Sale | 491.3 | 2026-03-03 |
| Kewalramani Reshma | director, officer: CEO & President | 2026-02-27 | S-Sale | 493.29 | 2026-03-03 |
| Kewalramani Reshma | director, officer: CEO & President | 2026-02-27 | S-Sale | 494.33 | 2026-03-03 |
| Kewalramani Reshma | director, officer: CEO & President | 2026-02-27 | S-Sale | 495.38 | 2026-03-03 |
| Kewalramani Reshma | director, officer: CEO & President | 2026-02-27 | S-Sale | 496.16 | 2026-03-03 |
| Kewalramani Reshma | director, officer: CEO & President | 2026-02-27 | S-Sale | 496.95 | 2026-03-03 |
| Bozic Carmen | officer: EVP and CMO | 2026-02-27 | S-Sale | 480.31 | 2026-03-03 |
| Ambrose Kristen | officer: SVP & Chief Accounting Officer | 2026-02-26 | S-Sale | 483.36 | 2026-03-02 |
| WAGNER CHARLES F JR | officer: EVP, CO & FO | 2026-02-24 | F-InKind | 485.11 | 2026-02-26 |
| Tatsis Ourania | officer: EVP, Chief Reg. & Quality Off. | 2026-02-24 | F-InKind | 485.11 | 2026-02-26 |
| Tatsis Ourania | officer: EVP, Chief Reg. & Quality Off. | 2026-02-25 | S-Sale | 486.35 | 2026-02-26 |
| Sachdev Amit | officer: EVP Chief Patient & Ext Af Off | 2026-02-24 | F-InKind | 485.11 | 2026-02-26 |
| Sachdev Amit | officer: EVP Chief Patient & Ext Af Off | 2026-02-25 | S-Sale | 486.35 | 2026-02-26 |
| McKechnie Duncan | officer: EVP, Chief Commercial Officer | 2026-02-24 | F-InKind | 485.11 | 2026-02-26 |
| McKechnie Duncan | officer: EVP, Chief Commercial Officer | 2026-02-25 | S-Sale | 486.35 | 2026-02-26 |
| McKechnie Duncan | officer: EVP, Chief Commercial Officer | 2026-02-25 | S-Sale | 489 | 2026-02-26 |
| LEIDEN JEFFREY M | director, officer: Executive Chairman | 2026-02-24 | F-InKind | 485.11 | 2026-02-26 |
| Kewalramani Reshma | director, officer: CEO & President | 2026-02-24 | F-InKind | 485.11 | 2026-02-26 |
| Bunnage Mark E. | officer: EVP, Chief Scientific Officer | 2026-02-24 | F-InKind | 485.11 | 2026-02-26 |
| Bunnage Mark E. | officer: EVP, Chief Scientific Officer | 2026-02-25 | S-Sale | 486.35 | 2026-02-26 |
| Bozic Carmen | officer: EVP and CMO | 2026-02-24 | F-InKind | 485.11 | 2026-02-26 |
| Biller Jonathan | officer: EVP and Chief Legal Officer | 2026-02-24 | F-InKind | 485.11 | 2026-02-26 |
| Biller Jonathan | officer: EVP and Chief Legal Officer | 2026-02-25 | S-Sale | 486.35 | 2026-02-26 |
| Atkinson Edward Morrow III | officer: EVP, Chief Technical Ops. Off. | 2026-02-24 | F-InKind | 485.11 | 2026-02-26 |
| Atkinson Edward Morrow III | officer: EVP, Chief Technical Ops. Off. | 2026-02-25 | S-Sale | 486.35 | 2026-02-26 |
| Ambrose Kristen | officer: SVP & Chief Accounting Officer | 2026-02-24 | F-InKind | 485.11 | 2026-02-26 |
| Ambrose Kristen | officer: SVP & Chief Accounting Officer | 2026-02-25 | S-Sale | 486.35 | 2026-02-26 |
| Sachdev Amit | officer: EVP Chief Patient & Ext Af Off | 2026-02-19 | M-Exempt | 187.53 | 2026-02-23 |
| Sachdev Amit | officer: EVP Chief Patient & Ext Af Off | 2026-02-19 | S-Sale | 463.91 | 2026-02-23 |
| Sachdev Amit | officer: EVP Chief Patient & Ext Af Off | 2026-02-19 | S-Sale | 465.05 | 2026-02-23 |
| Sachdev Amit | officer: EVP Chief Patient & Ext Af Off | 2026-02-19 | S-Sale | 465.8 | 2026-02-23 |
| Sachdev Amit | officer: EVP Chief Patient & Ext Af Off | 2026-02-19 | S-Sale | 467.75 | 2026-02-23 |
| Sachdev Amit | officer: EVP Chief Patient & Ext Af Off | 2026-02-19 | M-Exempt | 155.57 | 2026-02-23 |
| Sachdev Amit | officer: EVP Chief Patient & Ext Af Off | 2026-02-19 | S-Sale | 468.57 | 2026-02-23 |
| Sachdev Amit | officer: EVP Chief Patient & Ext Af Off | 2026-02-19 | S-Sale | 469.61 | 2026-02-23 |
| Sachdev Amit | officer: EVP Chief Patient & Ext Af Off | 2026-02-19 | S-Sale | 470.54 | 2026-02-23 |
| Sachdev Amit | officer: EVP Chief Patient & Ext Af Off | 2026-02-19 | S-Sale | 471.43 | 2026-02-23 |
| Sachdev Amit | officer: EVP Chief Patient & Ext Af Off | 2026-02-19 | M-Exempt | 155.57 | 2026-02-23 |
| Sachdev Amit | officer: EVP Chief Patient & Ext Af Off | 2026-02-19 | M-Exempt | 187.53 | 2026-02-23 |
| WAGNER CHARLES F JR | officer: EVP, CO & FO | 2026-02-17 | A-Award | 0 | 2026-02-19 |
| WAGNER CHARLES F JR | officer: EVP, CO & FO | 2026-02-17 | F-InKind | 483.75 | 2026-02-19 |
| Tatsis Ourania | officer: EVP, Chief Reg. & Quality Off. | 2026-02-17 | A-Award | 0 | 2026-02-19 |
| Tatsis Ourania | officer: EVP, Chief Reg. & Quality Off. | 2026-02-17 | F-InKind | 483.75 | 2026-02-19 |
| Tatsis Ourania | officer: EVP, Chief Reg. & Quality Off. | 2026-02-17 | S-Sale | 489.46 | 2026-02-19 |
| Tatsis Ourania | officer: EVP, Chief Reg. & Quality Off. | 2026-02-18 | S-Sale | 473.68 | 2026-02-19 |
| Sachdev Amit | officer: EVP Chief Patient & Ext Af Off | 2026-02-17 | A-Award | 0 | 2026-02-19 |
| Sachdev Amit | officer: EVP Chief Patient & Ext Af Off | 2026-02-17 | F-InKind | 483.75 | 2026-02-19 |
| McKechnie Duncan | officer: EVP, Chief Commercial Officer | 2026-02-17 | A-Award | 0 | 2026-02-19 |